Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.
A high proportion of end-stage kidney disease patients have suffered severe COVID-19 outcomes.
In an interview with HCPLive®, Alan S. Kliger, MD, a clinical professor of medicine at the Yale University School of Medicine, explained what has been discovered in regard to how likely nephrology patients are to end up with the more severe COVID-19 outcomes.
Certain kidney disease patients are also at a greater risk of contracting the virus.
“We know that chronic kidney disease patients, including dialysis patients, are more likely to become infected,” Kliger said. “And we know if infected they have a substantially worse prognosis than people without kidney disease.”
Kliger, who is also co-chair of the American Society of Nephrology Covid-19 Response Team, explained patients with chronic kidney disease, especially patients with end-stage kidney disease, are more likely to be infected because they have impaired immune systems. Kliger also said it is difficult for individuals to socially distance while undergoing dialysis.
However, since the initial outbreaks in the US, doctors and health care facilities have targeted different safety measures in order to reduce the viral load for patients and professionals, including requiring masks, staggering appointment times, and regular COVID-19 screenings to isolate infected individuals.